Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT)

Main Article Content

Vincent Piguet
Andrew Blauvelt
Daniel Burge
Luke Peterson
Janice Drew
Robert Rolleri
Jolanta Weglowska

Keywords

psoriasis, certolizumab, randomized trial, multicenter

Abstract

Abstract Not Available

 

Disclosure: Study supported by Dermira.